Strs Ohio Atreca, Inc. Transaction History

Strs Ohio

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 25, 2021	SELL	$13.03 - $17.09 $75,574 - $99,122	-5,800 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$12.52 - $23.45 $51,332 - $96,145	4,100 Added 241.18%	5,800 $123,000
Q3 2019 Oct 21, 2019	BUY	$10.42 - $22.04 $17,714 - $37,468	1,700 New	1,700 $20,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.